Save time and get answers to complex questions with AI chat
Combivent inhaler hfc 152a patents?Dabrafenib patent expiration?Cost promethazine price?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Drugpatentwatch skyrizi biologic patent analysis?
See the DrugPatentWatch profile for carisoprodol
Carisoprodol is classified as a centrally acting skeletal muscle relaxant. It is a prodrug that is metabolized to meprobamate (a sedative/anxiolytic). In the United States, carisoprodol is a Schedule IV controlled substance due to its potential for abuse and dependence.
Other Questions About Carisoprodol :